CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income		$ 2,135	$ 1,688
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred income taxes		(82)	(13)
Non-cash operating lease cost		46	48
Depreciation and amortization		88	152
Amortization of capitalized software development costs and intellectual property licenses	[1]	256	141
Share-based compensation expense	[2]	259	138
Realized and unrealized gain on equity investment (Note 6)		(36)	(3)
Other		(3)	15
Changes in operating assets and liabilities:
Accounts receivable, net		462	225
Software development and intellectual property licenses		(303)	(300)
Other assets		(88)	(179)
Deferred revenues		(818)	(322)
Accounts payable		(46)	(71)
Accrued expenses and other liabilities		(117)	(407)
Net cash provided by operating activities		1,753	1,112
Cash flows from investing activities:
Proceeds from maturities of available-for-sale investments		120	36
Proceeds from sale of available-for-sale investments		66	0
Purchases of available-for-sale investments		(248)	(158)
Capital expenditures		(59)	(56)
Other investing activities		20	0
Net cash used in investing activities		(101)	(178)
Cash flows from financing activities:
Proceeds from issuance of common stock to employees		78	114
Tax payment related to net share settlements on restricted stock units		(246)	(41)
Dividends paid		(365)	(316)
Proceeds from debt issuances, net of discounts		0	1,994
Repayment of long-term debt		0	(1,050)
Payment of financing costs		0	(20)
Premium payment for early redemption of note		0	(28)
Net cash (used in) provided by financing activities		(533)	653
Effect of foreign exchange rate changes on cash and cash equivalents		(35)	32
Net increase (decrease) in cash and cash equivalents and restricted cash		1,084	1,619
Cash and cash equivalents and restricted cash at beginning of period		8,652	5,798
Cash and cash equivalents and restricted cash at end of period		$ 9,736	$ 7,417

[1] Excludes deferral and amortization of share-based compensation expense.

[2] Includes the net effects of capitalization, deferral, and amortization of share-based compensation expense.